A real reason for patients with pseudobulbar affect to smile

Annals of Neurology

Volumn 61, Issue 2, 2007, Pages 92-96

  Rosen, Howard J ^a,b   Cummings, Jeffrey ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; DEXTROMETHORPHAN PLUS QUINIDINE; DOPAMINE RECEPTOR STIMULATING AGENT; IMIPRAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NORTRIPTYLINE; PENTOBARBITAL; RILUZOLE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

BRAIN INJURY; BRAIN STEM; BRAIN TUMOR; CLINICAL TRIAL; DEGENERATIVE DISEASE; DEPRESSION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DRUG DOSE ESCALATION; DRUG EFFICACY; EMOTIONAL DISORDER; FACIAL EXPRESSION; FOOD AND DRUG ADMINISTRATION; FRONTAL LOBE; GRAY MATTER; HUMAN; NEUROLOGIC DISEASE; PATHOLOGICAL CRYING; PATHOLOGICAL LAUGHTER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSEUDOBULBAR AFFECT; QUALITY OF LIFE; REVIEW; SOCIAL BEHAVIOR; STROKE; TREATMENT INDICATION; TREATMENT OUTCOME; WHITE MATTER;

AFFECTIVE SYMPTOMS; BRAIN DISEASES; HUMANS; LAUGHTER; SMILING; TERMINOLOGY AS TOPIC;

EID: 33847630860     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21056     Document Type: Review

References (42)

1. Brooks BR, Thisted RA, Appel SH, et al. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology 2004;63:1364-1370.
2. Panitch HS, Thisted RA, Smith RA, et al. Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis. Ann Neurol 2006;59:780-787.
3. Lieberman A, Benson DF. Control of emotional expression in pseudobulbar palsy. A personal experience. Arch Neurol 1977;34:717-719.
4. Poeck K. Pathophysiology of emotional disorders associated with brain damage. Handbook of clinical neurology. 1969;3:343-367.
5. Lawson IR, MacLeod RD. The use of imipramine ("Tofranil") and other psychotropic drugs in organic emotionalism. Br J Psychiatry 1969;115:281-285.
6. House A, Dennis M, Molyneux A, et al. Emotionalism after stroke. BMJ 1989;298:991-994.
7. Dark FL, McGrath JJ, Ron MA. Pathological laughing and crying. Aust N Z J Psychiatry 1996;30:472-479.
8. Arciniegas DB, Lauterbach EC, Anderson KE, et al. The differential diagnosis of pseudobulbar affect (PBA). Distinguishing PBA among disorders of mood and affect. Proceedings of a roundtable meeting. CNS Spectr 2005;10:1-16.
9. Darwin C. The expression of emotions in man and animals. New York: Appleton and Company, 1872.
10. Wilson SAK. Some problems in neurology: no. 2 pathological laughing and crying. J Neurol Psychopathol 1924;4:299-333.
11. Zeilig G, Drubach DA, Katz-Zeilig M, Karatinos J. Pathological laughter and crying in patients with closed traumatic brain injury. Brain Inj 1996;10:591-597.
12. Schiffer R, Pope LE. Review of pseudobulbar affect including a novel and potential therapy. J Neuropsychiatry Clin Neurosci 2005;17:447-454.
13. Gallagher JP. Pathologic laughter and crying in ALS: a search for their origin. Acta Neurol Scand 1989;80:114-117.
14. Kim JS, Choi S, Kwon SU, Seo YS. Inability to control anger or aggression after stroke. Neurology 2002;58:1106-1108.
15. Kim JS, Choi-Kwon S. Poststroke depression and emotional incontinence: correlation with lesion location. Neurology 2000;54:1805-1810.
16. Andersen G, Ingeman-Nielsen M, Vestergaard K, Riis JO. Pathoanatomic correlation between poststroke pathological crying and damage to brain areas involved in serotonergic neurotransmission. Stroke 1994;25:1050-1052.
17. Achari AN, Colover J. Posterior fossa tumors with pathological laughter. JAMA 1976;235:1469-1471.
18. Wisoff JH, Epstein FJ. Pseudobulbar palsy after posterior fossa operation in children. Neurosurgery 1984;15:707-709.
19. Tei H, Sakamoto Y. Pontine infarction due to basilar artery stenosis presenting as pathological laughter. Neuroradiology 1997;39:190-191.
20. Bhatjiwale MG, Nadkarni TD, Desai KI, Goel A. Pathological laughter as a presenting symptom of massive trigeminal neuromas: report of four cases. Neurosurgery 2000;47:469-472.
21. Parvizi J, Anderson SW, Martin CO, et al. Pathological laughter and crying: a link to the cerebellum. Brain 2001;124:1708-1719.
22. McCullagh S, Moore M, Gawel M, Feinstein A. Pathological laughing and crying in amyotrophic lateral sclerosis: an association with prefrontal cognitive dysfunction. J Neurol Sci 1999;169:43-48.
23. Feinstein A, O'Connor P, Gray T, Feinstein K. Pathological laughing and crying in multiple sclerosis: a preliminary report suggesting a role for the prefronral cortex. Mult Scler 1999;5:69-73.
24. Arciniegas DB. A clinical overview of pseudobulbar affect. Am J Geriatr Pharmacother 2005;3(suppl A):4-8; quiz 16-17.
25. Moore SR, Gresham LS, Bromberg MB, et al. A self report measure of affective lability. J Neurol Neurosurg Psychiatry 1997;63:89-93.
26. Nahas Z, Arlinghaus KA, Kotrla KJ, et al. Rapid response of emotional incontinence to selective serotonin reuptake inhibitors. J Neuropsychiatry Clin Neurosci 1998;10:453-455.
27. Allman P, Hope RA, Fairburn CG. Emotionalism following brain damage: a complex phenomenon. Postgrad Med J 1990;66:818-821.
28. Wild B, Rodden FA, Grodd W, Ruch W. Neural correlates of laughter and humour. Brain 2003;126:2121-2138.
29. Cummings JL, Arciniegas DB, Brooks BR, et al. Defining and diagnosing involuntary emotional expression disorder. CNS Spectr 2006;11:1-7.
30. Schiffer RB, Herndon RM, Rudick RA. Treatment of pathologic laughing and weeping with amitriptyline. N Engl J Med 1985;312:1480-1482.
31. Seliger GM, Hornstein A, Flax J, et al. Fluoxetine improves emotional incontinence. Brain Inj 1992;6:267-270.
32. Andersen G, Vestergaard K, Riis JO. Citalopram for post-stroke pathological crying. Lancet 1993;342:837-839.
33. Robinson RG, Parikh RM, Lipsey JR, et al. Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study. Am J Psychiatry 1993;150:286-293.
34. Burns A, Russell E, Stratton-Powell H, et al. Sertraline in stroke-associated lability of mood. Int J Geriatr Psychiatry 1999;14:681-685.
35. Murai T, Barthel H, Berrouschot J, et al. Neuroimaging of serotonin transporters in post-stroke pathological crying. Psychiatry Res 2003;123:207-211.
36. Kim SW, Shin IS, Kim JM, et al. Mirtazapine treatment for pathological laughing and crying after stroke. Clin Neuropharmacol 2005;28:249-251.
37. Udaka F, Yamao S, Nagata H, et al. Pathologic laughing and crying treated with levodopa. Arch Neurol 1984;41:1095-1096.
38. Wolf JK, Santana HB, Thorpy M. Treatment of "emotional incontinence" with levodopa. Neurology 1979;29:1435-1436.
39. Ramasubbu R. Lamotrigine treatment for post-stroke pathological laughing and crying. Clin Neuropharmacol 2003;26:233-235.
40. Palmer GC. Neuroprotection by NMDA receptor antagonises in a variety of neuropathologies. Curr Drug Targets 2001;2:241-271.
41. Su TP, Hayashi T. Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. Curr Med Chem 2003;10:2073-2080.
42. Kamei H, Kameyama T, Nabeshima T. Effects of sigma receptor ligands on conditioned fear stress. Methods Find Exp Clin Pharmacol 1998;20:613-618.